Skip to Content

Core Laboratories NV CLB Stock Quote

| Rating as of

NYSE:CLB

Morningstar‘s Stock Analysis CLB

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Slightly Lowering Wide-Moat Core Laboratories’ FVE to $29 on Near-Term End Market Volatility

Analyst Note

| Katherine Olexa |

After incorporating Core Laboratories’ full third-quarter financial results, we’re slightly lowering our fair value estimate to $29 (EUR 29)  from $32 (EUR 31). Our wide moat rating, stable moat trend, and Morningstar Uncertainty Rating of Very High are unchanged.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CLB

Company Profile CLB

Business Description

Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration, production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Contact
Van Heuven Goedhartlaan 7 B
Amstelveen, NH, 1181 LE, Netherlands
T +31 204203191
Sector Energy
Industry Oil & Gas Equipment & Services
Most Recent Earnings Sep 30, 2022
Fiscal Year End Dec 31, 2022
Employees 3,600

Related News CLB